Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A final common manifestation of a wide variety of chronic kidney diseases characterized by glomerulosclerosis and tubulointerstitial fibrosis.
Biomarker and diagnostic research for renal fibrosis has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include other interventions and procedural interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
284 publications have been identified in PubMed for renal fibrosis. Research spans Basic Science / Preclinical (68%), Review / Meta-Analysis (13%), and Gene Therapy / Novel Therapeutics (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 194 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:50 AM UTC
Research summaries | 38 | 13% |
New treatment approaches | 36 | 13% |
Testing and diagnosis research | 7 | 2% |
Disease patterns and progression | 5 | 2% |
Other research | 3 | 1% |
Clinical study results | 1 | 0% |
Wang Y (2026). [PMID: 40947460](https://pubmed.ncbi.nlm.nih.gov/40947460/). *Sci China Life Sci*. [Basic Science / Preclinical]
Huang Y (2026). [PMID: 41907221](https://pubmed.ncbi.nlm.nih.gov/41907221/). *J Inflamm Res*. [Basic Science / Preclinical]
Chen H (2026). [PMID: 42048031](https://pubmed.ncbi.nlm.nih.gov/42048031/). *Mol Cell Biochem*. [Review / Meta-Analysis]
Xie LJ (2026). [PMID: 41865690](https://pubmed.ncbi.nlm.nih.gov/41865690/). *Phytomedicine*. [Basic Science / Preclinical]
Zeng L (2026). [PMID: 42091254](https://pubmed.ncbi.nlm.nih.gov/42091254/). *Ren Fail*. [Review / Meta-Analysis]
Yang M (2026). [PMID: 41016357](https://pubmed.ncbi.nlm.nih.gov/41016357/). *Biomater Adv*. [Basic Science / Preclinical]
Yang C (2026). [PMID: 41909662](https://pubmed.ncbi.nlm.nih.gov/41909662/). *Front Immunol*. [Other]
Hu D (2026). [PMID: 42152940](https://pubmed.ncbi.nlm.nih.gov/42152940/). *J Inflamm Res*. [Review / Meta-Analysis]
Zhang J (2026). [PMID: 41637839](https://pubmed.ncbi.nlm.nih.gov/41637839/). *Exp Mol Pathol*. [Review / Meta-Analysis]
Wang Y (2026). [PMID: 41828542](https://pubmed.ncbi.nlm.nih.gov/41828542/). *International journal of molecular sciences*. [Basic Science / Preclinical]